(-)-3-deoxy-3-methylmorphine | 142835-98-1

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 吗啡烷
• 英文名称: (-)-3-deoxy-3-methylmorphine
• 英文别名: (4R,4aR,7S,7aR,12bS)-3,9-dimethyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol
• CAS: 142835-98-1
• 化学式: C₁₈H₂₁NO₂
• 分子量: 283.37
• InChiKey: IBGSIGRPLGVTPB-UKCJKJFHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  21
• 可旋转键数：
  0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  32.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (-)-3-deoxy-3-methylmorphine 在 甲烷磺酸 作用下， 反应 1.0h， 以82%的产率得到(-)-(R)-11-hydroxy-10-methylaporphine
  参考文献：
  名称：

  方便地合成海豚碱衍生物

  摘要：

  利用钯催化的反应的新的有效合成路线，从天然吗啡4提供（R）-11-羟基-10-甲基aporphine 2和（R）-11-羟基aporphine 3。

  DOI：

  10.1039/c39920000845
• 作为产物：
  描述：

  硫酸吗啡 在 bis-triphenylphosphine-palladium(II) chloride 三乙胺 、 三苯基膦 、 lithium chloride 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 (-)-3-deoxy-3-methylmorphine
  参考文献：
  名称：

  R-(−)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands

  摘要：

  Several N-substituted-11-hydroxy-10-hydroxymethyl- and 11-hydroxy-10-methylaporphines were synthesized and their binding affinities at dopamine D, and D, receptors and serotonin 5-HT1A and 5-HT2A receptors in rat forebrain tissue were evaluated. Tested compounds displayed moderate to high affinity to 5-HT1A receptors but low affinity to D, and D-2 receptors. The most potent novel 5-HT1A agent was R-(-)-N-methyl-10-hydroxymethyl-11-hydroxyaporphine. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.05.057

文献信息

• Efficient Synthesis Of Morphine And Codeine
  申请人：Magnus Philip D.

  公开号：US20100292475A1

  公开（公告）日：2010-11-18

  The present invention relates to methods for the synthesis of morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.

  本发明涉及吗啡、中间体、盐和衍生物的合成方法。在优选实施例中，本发明涉及改善吗啡、吗啡相关衍生物和中间体的效率和总产量的方法。在进一步实施例中，本发明涉及改善迷迭香碱及其中间体的效率和总产量的方法。
• Efficient Synthesis Of Galanthamine
  申请人：Magnus Philip D.

  公开号：US20100292466A1

  公开（公告）日：2010-11-18

  The present invention relates to methods for the synthesis of galanthamine, morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.

  本发明涉及合成迷达唑啉、吗啡、中间体、盐和衍生物的方法。在优选实施例中，本发明涉及提高吗啡、吗啡相关衍生物和中间体的效率和总产率的方法。在进一步的实施例中，本发明涉及提高迷达唑啉及其中间体的效率和总产率的方法。
• SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS
  申请人：President and Fellows of Harvard College

  公开号：US20140058106A1

  公开（公告）日：2014-02-27

  Described herein are fluorinated organic compounds and methods of making fluorinated organic compounds, for example, using palladium complexes. Also described herein are compositions and kits containing compounds and palladium complexes described herein.

  本文描述了氟化有机化合物及制备氟化有机化合物的方法，例如使用钯配合物。本文还描述了包含所述化合物和钯配合物的组合物和工具包。
• Cross-conjugated 2,5-cyclohexadienone and related synthesis methods
  申请人：Magnus Philip D.

  公开号：US20100292489A1

  公开（公告）日：2010-11-18

  The present invention relates to methods for the synthesis of galanthamine, morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.

  本发明涉及合成无花果碱、吗啡、中间体、盐和衍生物的方法。在优选实施例中，本发明涉及改善吗啡、吗啡相关衍生物和中间体的效率和总产率的方法。在进一步的实施例中，本发明涉及改善无花果碱及其中间体的效率和总产率的方法。
• (R)-11-Hydroxy- and (R)-11-Hydroxy-10-methylaporphine: Synthesis, Pharmacology, and Modeling of D2A and 5-HT1A Receptor Interactions
  作者：Martin H. Hedberg、Anette M. Johansson、Gunnar Nordvall、Ari Yliniemela、Hong Bing Li、Arnold R. Martin、Stephan Hjorth、Lena Unelius、Staffan Sundell、Uli Hacksell

  DOI：10.1021/jm00004a011

  日期：1995.2

  (R)-11-Hydroxyaporphine (2) and (R)-11-hydroxy-10-methylaporphine (3) were synthesized from natural morphine by using new, short, and efficient synthetic sequences. The dopaminergic and serotonergic effects of 2 and 3 were evaluated by use of in vitro and in vivo test systems. The results indicate that 3 is a potent, selective, and efficacious 6-HT1A receptor agonist. In contrast, 2 is a partial 5-HT1A receptor agonist of low potency which has affinity also for central D-1 and D-2A receptors. The differences in pharmacological profiles were rationalized by modeling of ligand-receptor interactions using homology-based receptor models of the 6-HT1A and D-2A receptor binding site. The selective and pronounced serotonergic effects of 3 appear to be due to the CIO-methyl group, which is accommodated by a lipophilic pocket in the 5-HT1A receptor. In contrast, the C10-methyl group of 3 is not accommodated by the binding site model of the D-2A receptor.